Market Cap 2.17B
Revenue (ttm) 225.21M
Net Income (ttm) -15.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.97%
Debt to Equity Ratio 0.01
Volume 651,400
Avg Vol 1,047,930
Day's Range N/A - N/A
Shares Out 53.18M
Stochastic %K 20%
Beta 1.17
Analysts Strong Sell
Price Target $50.00

Company Profile

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wra...

Industry: Medical Devices
Sector: Healthcare
Phone: 386 462 6800
Fax: 386 462 6801
Address:
13631 Progress Boulevard, Suite 400, Alachua, United States
dustin1101
dustin1101 May. 11 at 2:50 PM
$AXGN Def getting knocked down by more insider sales but I bet they’re almost done. Mkt is strong. Adding here.
0 · Reply
dustin1101
dustin1101 May. 8 at 6:56 PM
$AXGN I’m betting $ this is down on planned insider sales hitting the tape indiscriminately. This has happened in quarters past post ER and when they’re done it floats back up.
0 · Reply
dustin1101
dustin1101 May. 6 at 2:11 PM
$AXGN you can always count on these discount sellers to reload what you trim into a strong close. lol
0 · Reply
dustin1101
dustin1101 May. 5 at 2:55 PM
$AXGN shorts under pressure across many squeezy names this morning. They seem to be a little nervous here after pushing down to a .618 test and now right back up to .382.. So thin, $44.50 lets go.
0 · Reply
dustin1101
dustin1101 May. 4 at 4:11 PM
$AXGN might catch a bid with bio sector standing out today. We'll see, stuck under the .5 fib now.
0 · Reply
dustin1101
dustin1101 May. 4 at 1:46 PM
$AXGN Respecting fib levels pretty well. In a range between 50% (42.70) and 38.2% (43.50) levels on the ER move. Next level up is 23.6% or approx $44.50. Watch the mkt. 61.8% is stronger support at just below $42.
0 · Reply
PenkeInvesting
PenkeInvesting May. 1 at 11:11 AM
Fundamental analysis of $AXGN (Axogen, Inc.) based on financial data and reported results. #AXGN
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 10:03 PM
$AXGN Share Price: $43.21 Contract Selected: Oct 16, 2026 $45 Calls Buy Zone: $4.08 – $5.04 Target Zone: $6.54 – $8.00 Potential Upside: 51% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Pika_Capital
Pika_Capital Apr. 30 at 7:06 PM
$AXGN wow sold years ago and now they are back to $40S .
0 · Reply
LuckEtradER
LuckEtradER Apr. 30 at 2:20 PM
$AXGN what a beast
2 · Reply
Latest News on AXGN
AxoGen price target raised to $48 from $41 at Raymond James

2026-04-29T16:57:39.000Z - 13 days ago

AxoGen price target raised to $48 from $41 at Raymond James


AxoGen price target raised to $50 from $45 at Canaccord

2026-04-29T13:02:40.000Z - 13 days ago

AxoGen price target raised to $50 from $45 at Canaccord


AxoGen price target raised to $50 from $39 at H.C. Wainwright

2026-04-29T10:16:26.000Z - 14 days ago

AxoGen price target raised to $50 from $39 at H.C. Wainwright


AxoGen price target raised to $50 from $42 at Citizens

2026-04-29T09:53:29.000Z - 14 days ago

AxoGen price target raised to $50 from $42 at Citizens


AxoGen rises 12.8%

2026-04-28T14:28:46.000Z - 14 days ago

AxoGen rises 12.8%


Axogen Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:00 AM EDT - 15 days ago

Axogen Earnings Call Transcript: Q1 2026


AxoGen reports Q1 adjusted EPS 7c, consensus 7c

2026-04-28T11:08:24.000Z - 15 days ago

AxoGen reports Q1 adjusted EPS 7c, consensus 7c


Axogen, Inc. Reports First Quarter 2026 Financial Results

Apr 28, 2026, 7:00 AM EDT - 15 days ago

Axogen, Inc. Reports First Quarter 2026 Financial Results


AxoGen price target raised to $45 from $40 at Canaccord

2026-04-24T11:16:41.000Z - 19 days ago

AxoGen price target raised to $45 from $40 at Canaccord


AxoGen price target raised to $50 from $40 at Lake Street

2026-04-23T12:44:20.000Z - 19 days ago

AxoGen price target raised to $50 from $40 at Lake Street


AxoGen jumps after Cigna picks up Avance nerve graft

2026-04-16T20:00:22.000Z - 26 days ago

AxoGen jumps after Cigna picks up Avance nerve graft

CI


Axogen Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 12:30 PM EDT - 2 months ago

Axogen Transcript: The Citizens Life Sciences Conference 2026


Axogen Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 1:00 PM EDT - 2 months ago

Axogen Transcript: Leerink Global Healthcare Conference 2026


Axogen Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 2 months ago

Axogen Earnings Call Transcript: Q4 2025


AxoGen reports Q4 adjusted EPS 7c, consensus 10c

2026-02-24T12:06:53.000Z - 2 months ago

AxoGen reports Q4 adjusted EPS 7c, consensus 10c


AxoGen sees FY26 revenue $265.7M, consensus $259.53M

2026-02-24T12:05:30.000Z - 2 months ago

AxoGen sees FY26 revenue $265.7M, consensus $259.53M


AxoGen price target raised to $42 from $34 at Citizens

2026-02-24T10:40:34.000Z - 2 months ago

AxoGen price target raised to $42 from $34 at Citizens


AxoGen price target raised to $41 from $36 at Raymond James

2026-02-23T14:45:11.000Z - 2 months ago

AxoGen price target raised to $41 from $36 at Raymond James


AxoGen initiated with an Overweight at Wells Fargo

2026-02-19T10:55:34.000Z - 2 months ago

AxoGen initiated with an Overweight at Wells Fargo


AxoGen 4M share Spot Secondary priced at $31.00

2026-01-22T13:46:34.000Z - 3 months ago

AxoGen 4M share Spot Secondary priced at $31.00


AxoGen announces $85M common stock offering

2026-01-21T21:16:01.000Z - 3 months ago

AxoGen announces $85M common stock offering


Axogen Announces Proposed Public Offering of Common Stock

Jan 21, 2026, 4:09 PM EST - 3 months ago

Axogen Announces Proposed Public Offering of Common Stock


AxoGen files automatic mixed securities shelf

2026-01-21T21:05:26.000Z - 3 months ago

AxoGen files automatic mixed securities shelf


AxoGen files automatic mixed securities shelf

2026-01-21T21:05:17.000Z - 3 months ago

AxoGen files automatic mixed securities shelf


Axogen Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 15, 2026, 1:30 PM EST - 4 months ago

Axogen Transcript: 44th Annual J.P. Morgan Healthcare Conference


FDA approves Axogen's nerve repair graft

Dec 3, 2025, 6:53 PM EST - 5 months ago

FDA approves Axogen's nerve repair graft


Axogen Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 11:30 AM EST - 6 months ago

Axogen Transcript: Jefferies London Healthcare Conference 2025


Axogen Earnings Call Transcript: Q3 2025

Oct 29, 2025, 8:00 AM EDT - 7 months ago

Axogen Earnings Call Transcript: Q3 2025


Axogen, Inc. Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 7:00 AM EDT - 7 months ago

Axogen, Inc. Reports Third Quarter 2025 Financial Results


Axogen Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Axogen Earnings Call Transcript: Q2 2025


Axogen Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Axogen Earnings Call Transcript: Q1 2025


Axogen, Inc. Reports 2025 First Quarter Financial Results

May 8, 2025, 7:05 AM EDT - 1 year ago

Axogen, Inc. Reports 2025 First Quarter Financial Results


Axogen Transcript: Investor Day 2025

Mar 4, 2025, 9:00 AM EST - 1 year ago

Axogen Transcript: Investor Day 2025


Axogen Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Axogen Earnings Call Transcript: Q4 2024


Axogen, Inc. To Host Analyst & Investor Day on March 4th

Feb 25, 2025, 7:10 AM EST - 1 year ago

Axogen, Inc. To Host Analyst & Investor Day on March 4th


Axogen Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Axogen Earnings Call Transcript: Q3 2024


Axogen Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Axogen Earnings Call Transcript: Q2 2024


Axogen, Inc. Announces New Leadership Appointments

Aug 8, 2024, 7:05 AM EDT - 1 year ago

Axogen, Inc. Announces New Leadership Appointments


Axogen Earnings Call Transcript: Q1 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

Axogen Earnings Call Transcript: Q1 2024


Axogen, Inc Reports First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 2 years ago

Axogen, Inc Reports First Quarter 2024 Financial Results


Axogen Earnings Call Transcript: Q4 2023

Mar 5, 2024, 8:00 AM EST - 2 years ago

Axogen Earnings Call Transcript: Q4 2023


Axogen Announces Promotions on Research and Development Team

Jan 4, 2024, 4:35 PM EST - 2 years ago

Axogen Announces Promotions on Research and Development Team


Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Dec 26, 2023, 4:15 PM EST - 2 years ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors


Axogen Announces Transition of Finance Team Leadership

Dec 6, 2023, 7:00 AM EST - 2 years ago

Axogen Announces Transition of Finance Team Leadership


Axogen Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Axogen Earnings Call Transcript: Q3 2023


Axogen, Inc. Reports 2023 Third Quarter Financial Results

Nov 7, 2023, 7:00 AM EST - 2 years ago

Axogen, Inc. Reports 2023 Third Quarter Financial Results


Axogen to Participate at Upcoming Investor Conferences

Aug 31, 2023, 7:00 AM EDT - 2 years ago

Axogen to Participate at Upcoming Investor Conferences


Axogen Earnings Call Transcript: Q2 2023

Aug 7, 2023, 4:30 PM EDT - 3 years ago

Axogen Earnings Call Transcript: Q2 2023


Axogen, Inc. Reports 2023 Second Quarter Financial Results

Aug 7, 2023, 4:01 PM EDT - 3 years ago

Axogen, Inc. Reports 2023 Second Quarter Financial Results


dustin1101
dustin1101 May. 11 at 2:50 PM
$AXGN Def getting knocked down by more insider sales but I bet they’re almost done. Mkt is strong. Adding here.
0 · Reply
dustin1101
dustin1101 May. 8 at 6:56 PM
$AXGN I’m betting $ this is down on planned insider sales hitting the tape indiscriminately. This has happened in quarters past post ER and when they’re done it floats back up.
0 · Reply
dustin1101
dustin1101 May. 6 at 2:11 PM
$AXGN you can always count on these discount sellers to reload what you trim into a strong close. lol
0 · Reply
dustin1101
dustin1101 May. 5 at 2:55 PM
$AXGN shorts under pressure across many squeezy names this morning. They seem to be a little nervous here after pushing down to a .618 test and now right back up to .382.. So thin, $44.50 lets go.
0 · Reply
dustin1101
dustin1101 May. 4 at 4:11 PM
$AXGN might catch a bid with bio sector standing out today. We'll see, stuck under the .5 fib now.
0 · Reply
dustin1101
dustin1101 May. 4 at 1:46 PM
$AXGN Respecting fib levels pretty well. In a range between 50% (42.70) and 38.2% (43.50) levels on the ER move. Next level up is 23.6% or approx $44.50. Watch the mkt. 61.8% is stronger support at just below $42.
0 · Reply
PenkeInvesting
PenkeInvesting May. 1 at 11:11 AM
Fundamental analysis of $AXGN (Axogen, Inc.) based on financial data and reported results. #AXGN
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 10:03 PM
$AXGN Share Price: $43.21 Contract Selected: Oct 16, 2026 $45 Calls Buy Zone: $4.08 – $5.04 Target Zone: $6.54 – $8.00 Potential Upside: 51% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Pika_Capital
Pika_Capital Apr. 30 at 7:06 PM
$AXGN wow sold years ago and now they are back to $40S .
0 · Reply
LuckEtradER
LuckEtradER Apr. 30 at 2:20 PM
$AXGN what a beast
2 · Reply
dustin1101
dustin1101 Apr. 30 at 1:41 PM
$AXGN seeing a little rotation into bio this morning.. look at $XBI
0 · Reply
dustin1101
dustin1101 Apr. 29 at 5:14 PM
$AXGN my view.. you can either sell here and maybe reload a gap fill or a bit lower. Or hold until the buyers outweigh the sellers, as they have come to consistently over the past year. There's also always the risk of being out in the event of an acquisition or payer update. I'm holding/already reloaded the vast majority. GLTA.
1 · Reply
IN0V8
IN0V8 Apr. 29 at 3:53 PM
$AXGN Mizuho raises target price to $55 from $40 Raymond James raises target price to $48 from $41 H.C. Wainwright raises target price to $50 from $39 Wells Fargo raises target price to $48 from $40
0 · Reply
dustin1101
dustin1101 Apr. 29 at 12:20 PM
$AXGN Mizhuo $40 >> $55, Citizens $42 >> $50, HC Wainright $39 >> $50, Wells Fargo $40 >> $48, Raymond James $41 >> $48, Cannacord $45 >> $50,
0 · Reply
DARKP00L
DARKP00L Apr. 29 at 11:57 AM
$AXGN 07:35 on Apr. 29 2026 HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $50 #tradeideas
0 · Reply
Quantumup
Quantumup Apr. 29 at 10:26 AM
Citizens⬆️ $AXGN's PT to $50 from $42 and reiterated at Market Outperform. $BAX $SYK IART MDGX Mizuho⬆️PT to $55 from $40 and reiterated at Outperform. Here's what Citizens and Mizuho had to say: https://x.com/Quantumup1/status/2049434277276758434?s=20
0 · Reply
WallStWingman
WallStWingman Apr. 28 at 8:23 PM
Shaved some on the earnings beat this morning and now we trail the rest $AXGN
0 · Reply
dustin1101
dustin1101 Apr. 28 at 7:53 PM
$AXGN buying some EOD here. Looking forward to seeing new PT's $50+
0 · Reply
dustin1101
dustin1101 Apr. 28 at 2:25 PM
$AXGN who's left to sell this $50+ stock down here?
0 · Reply
VolterX
VolterX Apr. 28 at 1:56 PM
$AXGN thin but bid support showing, breakout risk builds if volume sneaks in
0 · Reply
AlphaBull_10M
AlphaBull_10M Apr. 28 at 1:52 PM
Pre market gainers led by $OMCL $DDI $KNSA $AXGN $SEI
0 · Reply
Doozio
Doozio Apr. 28 at 1:46 PM
$AXGN ONTO 🐒🍌🧠⏰♾️
0 · Reply